Since dTMP is an essential precursor of DNA, any agent that lowers dTMP levels drastically affects cell division. Because rapidly dividing cells are particularly dependent on the activities of thymidylate synthase and dihydrefolate reductase, these enzymes have been major targets for anti-cancer drugs. The inhibition of either or both of these enzymes blocks the synthesis of dTMP and therefore the synthesis of DNA.